rs12148604

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000103.4(CYP19A1):​c.*1601G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.458 in 152,038 control chromosomes in the GnomAD database, including 16,474 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.46 ( 16474 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

CYP19A1
NM_000103.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.658

Publications

14 publications found
Variant links:
Genes affected
CYP19A1 (HGNC:2594): (cytochrome P450 family 19 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and catalyzes the last steps of estrogen biosynthesis. Mutations in this gene can result in either increased or decreased aromatase activity; the associated phenotypes suggest that estrogen functions both as a sex steroid hormone and in growth or differentiation. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]
MIR4713HG (HGNC:53124): (MIR4713 host gene)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 15-51209207-C-T is Benign according to our data. Variant chr15-51209207-C-T is described in ClinVar as Benign. ClinVar VariationId is 316454.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.522 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000103.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP19A1
NM_000103.4
MANE Select
c.*1601G>A
3_prime_UTR
Exon 10 of 10NP_000094.2
CYP19A1
NM_001347248.1
c.*1601G>A
3_prime_UTR
Exon 10 of 10NP_001334177.1P11511-1
CYP19A1
NM_001347249.2
c.*1601G>A
3_prime_UTR
Exon 10 of 10NP_001334178.1P11511-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP19A1
ENST00000396402.6
TSL:1 MANE Select
c.*1601G>A
3_prime_UTR
Exon 10 of 10ENSP00000379683.1P11511-1
MIR4713HG
ENST00000559909.1
TSL:4
n.195-68776C>T
intron
N/A
MIR4713HG
ENST00000805692.1
n.279-68776C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.458
AC:
69603
AN:
151920
Hom.:
16472
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.356
Gnomad AMI
AF:
0.523
Gnomad AMR
AF:
0.385
Gnomad ASJ
AF:
0.551
Gnomad EAS
AF:
0.498
Gnomad SAS
AF:
0.332
Gnomad FIN
AF:
0.524
Gnomad MID
AF:
0.411
Gnomad NFE
AF:
0.527
Gnomad OTH
AF:
0.466
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.458
AC:
69631
AN:
152038
Hom.:
16474
Cov.:
32
AF XY:
0.454
AC XY:
33739
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.356
AC:
14739
AN:
41452
American (AMR)
AF:
0.385
AC:
5878
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.551
AC:
1909
AN:
3466
East Asian (EAS)
AF:
0.497
AC:
2577
AN:
5180
South Asian (SAS)
AF:
0.333
AC:
1607
AN:
4822
European-Finnish (FIN)
AF:
0.524
AC:
5537
AN:
10574
Middle Eastern (MID)
AF:
0.408
AC:
119
AN:
292
European-Non Finnish (NFE)
AF:
0.527
AC:
35808
AN:
67954
Other (OTH)
AF:
0.464
AC:
980
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1904
3807
5711
7614
9518
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
632
1264
1896
2528
3160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.481
Hom.:
10619
Bravo
AF:
0.447
Asia WGS
AF:
0.381
AC:
1325
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Aromatase deficiency (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
7.7
DANN
Benign
0.61
PhyloP100
0.66
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12148604; hg19: chr15-51501404; API